Debio-025 (alisporivir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Debio-025 (alisporivir), covering 2016-04-20 to 2016-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients [NA]